Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × vatalanib × Clear all

NCT00216047 2015-12-09

PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms